Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study

Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study


  • Amos Lal Mayo Clinic, Rochester MN, USA https://orcid.org/0000-0002-0021-2033
  • Nurul Haque Department of Medicine Merit Health River Region Hospital 2100 US-61, Vicksburg, MS 39183
  • Jennifer Lee Clinical Pharmacy Coordinator, Critical Care Department of Pharmacy 123 Summer Street Saint Vincent Hospital, Worcester, Massachusetts. USA 01608
  • Sai Ramya Katta Clinical Pharmacy Coordinator, Critical Care Department of Pharmacy 123 Summer Street Saint Vincent Hospital, Worcester, Massachusetts. USA 01608
  • Louise Maranda Department of Biostatistics University of Massachusetts Medical School
  • Susan George Clinical Associate Professor of Medicine University of Massachusetts Medical School Program Director, Internal Medicine Residency Chair, Department of Medicine Performance Improvement Committee 123 Summer Street Saint Vincent Hospital, Worcester, Massachusetts.
  • Nitin Trivedi Director, Division of Endocrinology Associate Program Director, Internal Medicine Residency Department of Medicine, Saint Vincent Hospital Associate Professor of Medicine University of Massachusetts Medical School 123 Summer Street Saint Vincent Hospital, Worcester, Massachusetts


Hyperglycemia, Critically ill, Insulin Infusion, Hypoglycemia, Blood Glucose


Objective: The American Diabetes Association and the Society of Critical Care Medicine recommend monitoring blood glucose (BG) every 1-2 hours in patients receiving insulin infusion to guide titration of insulin infusion to maintain serum glucose in the target range; however, this is based on weak evidence. We evaluated the compliance of hourly BG monitoring and relation of less frequent BG monitoring to glycemic status.

Materials and Methods: Retrospective chart review performed on 56 consecutive adult patients who received intravenous insulin infusion for persistent hyperglycemia in the ICU at Saint Vincent Hospital, a tertiary care community hospital an urban setting in Northeast region of USA. The frequency of fingerstick blood glucose (FSBG) readings was reviewed for compliance with hourly FSBG monitoring per protocol and the impact of FSBG testing at different time intervals on the glycemic status. Depending on time interval of FSBG monitoring, the data was divided into three groups: Group A (<90 min), Group B (91-179 min) and Group C (≥180 min).

Results: The mean age was 69 years (48% were males), 77% patients had preexisting type 2 diabetes mellitus (T2DM). The mean MPM II score was 41. Of the 1411 readings for BG monitoring on insulin infusion, 467 (33%) were in group A, 806 (57%) in group B and 138 (10%) in group C; hourly BG monitoring compliance was 12.6%. The overall glycemic status was similar among all groups. There were 14 (0.99%) hypoglycemic episodes observed. The rate of hypoglycemic episodes was similar in all three groups (p=0.55).

Conclusion: In patients requiring insulin infusion for sustained hyperglycemia in ICU, the risk of hypoglycemic episodes was not significantly different with less frequent BG monitoring. The compliance to hourly blood glucose monitoring and ICU was variable, and hypoglycemic episodes were similar across the groups despite the variation in monitoring.


Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract. 2009 May-Jun;15(4):353-69. doi: 10.4158/ep09102.ra. PubMed PMID: 19454396; eng.

Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012 Dec;40(12):3251-76. doi: 10.1097/CCM.0b013e3182653269. PubMed PMID: 23164767; eng.

Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009 Mar 26;360(13):1283-97. doi: 10.1056/NEJMoa0810625. PubMed PMID: 19318384; eng.

Egi M, Furushima N. Glycemic control in acute illness. 2017 Dec;70(6):591-595. doi: 10.4097/kjae.2017.70.6.591. PubMed PMID: 29225740.

Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004 Feb;27(2):461-7. PubMed PMID: 14747229; eng.

Beesley SJ, Hirshberg EL, Lanspa MJ. Glucose management in the intensive care unit: are we looking for the right sweet spot? Annals of translational medicine. 2016;4(18):347-347. doi: 10.21037/atm.2016.08.30. PubMed PMID: 27761451.

Kar P, Plummer MP, Bellomo R, et al. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study. Crit Care Med. 2016 Sep;44(9):1695-703. doi: 10.1097/ccm.0000000000001815. PubMed PMID: 27315191; eng.

Finfer S, Liu B, Chittock DR, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012 Sep 20;367(12):1108-18. doi: 10.1056/NEJMoa1204942. PubMed PMID: 22992074; eng.

McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001 Jan;17(1):107-24. PubMed PMID: 11219223; eng.

Klonoff DC. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol. 2011 May 1;5(3):755-67. doi: 10.1177/193229681100500330. PubMed PMID: 21722591; PubMed Central PMCID: PMCPmc3192642. eng.

Kelly JL. Continuous Insulin Infusion: When, Where, and How? Diabetes Spectr. 2014 Aug;27(3):218-23. doi: 10.2337/diaspect.27.3.218. PubMed PMID: 26246783; PubMed Central PMCID: PMCPmc4523736. eng.

Passarelli AJ, Gibbs H, Rowden AM, et al. Evaluation of a Nurse-Managed Insulin Infusion Protocol. Diabetes Technology & Therapeutics. 2016;18(2):93-99. doi: 10.1089/dia.2015.0046. PubMed PMID: PMC4808278.

Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006 Feb 2;354(5):449-61. doi: 10.1056/NEJMoa052521. PubMed PMID: 16452557; eng.

van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001 Nov 8;345(19):1359-67. doi: 10.1056/NEJMoa011300. PubMed PMID: 11794168; eng.

Bouw JW, Campbell N, Hull MA, et al. A retrospective cohort study of a nurse-driven computerized insulin infusion program versus a paper-based protocol in critically ill patients. Diabetes Technol Ther. 2012 Feb;14(2):125-30. doi: 10.1089/dia.2011.0130. PubMed PMID: 22011007; eng.

Dortch MJ, Mowery NT, Ozdas A, et al. A computerized insulin infusion titration protocol improves glucose control with less hypoglycemia compared to a manual titration protocol in a trauma intensive care unit. JPEN J Parenter Enteral Nutr. 2008 Jan-Feb;32(1):18-27. doi: 10.1177/014860710803200118. PubMed PMID: 18165443; eng.

Hoekstra M, Vogelzang M, Verbitskiy E, et al. Health technology assessment review: Computerized glucose regulation in the intensive care unit--how to create artificial control. Crit Care. 2009;13(5):223. doi: 10.1186/cc8023. PubMed PMID: 19849827; PubMed Central PMCID: PMCPmc2784347. eng.

Lee J, Fortlage D, Box K, et al. Computerized insulin infusion programs are safe and effective in the burn intensive care unit. J Burn Care Res. 2012 May-Jun;33(3):e114-9. doi: 10.1097/BCR.0b013e3182331e39. PubMed PMID: 22079904; eng.

Marvin MR, Inzucchi SE, Besterman BJ. Computerization of the Yale insulin infusion protocol and potential insights into causes of hypoglycemia with intravenous insulin. Diabetes Technol Ther. 2013 Mar;15(3):246-52. doi: 10.1089/dia.2012.0277. PubMed PMID: 23289409; PubMed Central PMCID: PMCPmc3696925. eng.

Olinghouse C. Development of a computerized intravenous insulin application (AutoCal) at Kaiser Permanente Northwest, integrated into Kaiser Permanente HealthConnect: impact on safety and nursing workload. Perm J. 2012 Summer;16(3):67-70. PubMed PMID: 23012605; PubMed Central PMCID: PMCPmc3442768. eng.

Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009 Oct;35(10):1738-48. doi: 10.1007/s00134-009-1585-2. PubMed PMID: 19636533; eng.

Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008 Jan 10;358(2):125-39. doi: 10.1056/NEJMoa070716. PubMed PMID: 18184958; eng.

Lipshutz AK, Gropper MA. Perioperative glycemic control: an evidence-based review. Anesthesiology. 2009 Feb;110(2):408-21. doi: 10.1097/ALN.0b013e3181948a80. PubMed PMID: 19194167; eng.

Krikorian A, Ismail-Beigi F, Moghissi ES. Comparisons of different insulin infusion protocols: a review of recent literature. Curr Opin Clin Nutr Metab Care. 2010 Mar;13(2):198-204. doi: 10.1097/MCO.0b013e32833571db. PubMed PMID: 20040862; eng.

Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med. 2007 Oct;35(10):2262-7. doi: 10.1097/01.ccm.0000282073.98414.4b. PubMed PMID: 17717490; eng.

Rood E, Bosman RJ, van der Spoel JI, et al. Use of a computerized guideline for glucose regulation in the intensive care unit improved both guideline adherence and glucose regulation. J Am Med Inform Assoc. 2005 Mar-Apr;12(2):172-80. doi: 10.1197/jamia.M1598. PubMed PMID: 15561795; PubMed Central PMCID: PMCPmc551549. eng.




How to Cite

Lal A, Haque N, Lee J, Katta SR, Maranda L, George S, et al. Optimal Blood Glucose Monitoring Interval for Insulin Infusion in Critically Ill Non-Cardiothoracic Patients: A Pilot Study . Acta Biomed [Internet]. 2021 Feb. 25 [cited 2024 Jul. 12];92(1):e2021036. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9083